Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REBECCA Real-world Early BrEast CanCer mAnagement REBECCA. a French National Multicentric Real-world Study of Early Breast Cancer Patients

NCT06856343 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06856343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06856343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REBECCA Real-world Early BrEast CanCer mAnagement REBECCA. a French National Multicentric Real-world Study of Early Breast Cancer Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
December 30, 2024
Completion date
January 31, 2028
Enrollment
126 (estimated)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer